Citation

BibTex format

@inproceedings{Hugo:2024:10.1183/13993003.congress-2024.PA2980,
author = {Hugo, T and Harper, AR and Leander, J and Lundin, P and Bock, D and Zhou, X-H and Bondarenko, I and Burns, S and Wiegert, E and Fitzgerald, MF and Close, DR and Keeling, DJ and Pandya, H and Belvisi, MG and O'Byrne, PM},
doi = {10.1183/13993003.congress-2024.PA2980},
publisher = {EUROPEAN RESPIRATORY SOC JOURNALS LTD},
title = {APATURA: a Phase 2a study of elarekibep, an inhaled IL-4 receptor alpha inhibitor, in moderate-to-severe asthma},
url = {http://dx.doi.org/10.1183/13993003.congress-2024.PA2980},
year = {2024}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Hugo,T
AU  - Harper,AR
AU  - Leander,J
AU  - Lundin,P
AU  - Bock,D
AU  - Zhou,X-H
AU  - Bondarenko,I
AU  - Burns,S
AU  - Wiegert,E
AU  - Fitzgerald,MF
AU  - Close,DR
AU  - Keeling,DJ
AU  - Pandya,H
AU  - Belvisi,MG
AU  - O'Byrne,PM
DO  - 10.1183/13993003.congress-2024.PA2980
PB  - EUROPEAN RESPIRATORY SOC JOURNALS LTD
PY  - 2024///
SN  - 0903-1936
TI  - APATURA: a Phase 2a study of elarekibep, an inhaled IL-4 receptor alpha inhibitor, in moderate-to-severe asthma
UR  - http://dx.doi.org/10.1183/13993003.congress-2024.PA2980
ER  -
Download